首页/数据集/MOESM1 of A novel epigenetic signature for overall survival prediction in patients with breast cancer

MOESM1 of A novel epigenetic signature for overall survival prediction in patients with breast cancer

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/MOESM1_of_A_novel_epigenetic_signature_for_overall_survival_prediction_in_patients_with_breast_cancer/10566539 数据链接链接失效反馈

官方服务：

资源简介：

Additional file 1.Â Clinical informations for TCGA cohort

应用场景：

创建时间：

2019-11-20

癌症预后预测

肥胖生物标志物

The improvement in the quality of life is accompanied by an accelerated pace of living and increased work-related pressures. Recent decades has seen an increase in the proportion of obese patients, as

NIAID Data Ecosystem30

Table_1_A Novel Ferroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Breast Cancer.XLSX

癌症预后预测

铁死亡基因

IntroductionBreast cancer is the most common malignant tumor in women worldwide. However, advanced multidisciplinary therapy cannot rescue the mortality of high-risk breast cancer metastasis. Ferropto

NIAID Data Ecosystem20

DataSheet_1_A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer.zip

癌症预后预测

肿瘤生物标志物

BackgroundGamma-aminobutyric acid (GABA) participates in the migration, differentiation, and proliferation of tumor cells. However, the GABA-related risk signature has never been investigated. Hence,

NIAID Data Ecosystem10

Table_3_A Five-Gene-Pair-Based Prognostic Signature for Predicting the Relapse Risk of Early Stage ER+ Breast Cancer.XLSX

癌症预后预测

复发风险评估

About 20–30% of early-stage breast cancer patients suffer relapses after surgery. To identify such high-risk patients, many signatures have been reported, but they lack robustness in data measured on

NIAID Data Ecosystem30

The transcriptional signature for Hepatocyte Growth Factor-driven invasive growth predicts poor prognosis of human hepatocellular carcinoma.

肝癌侵袭性生长

癌症预后预测

During embryogenesis, Hepatocyte Growth Factor (HGF) elicits a distinctive morphogenetic program, the invasive growth, by the activation of MET, whose aberrant activation in cancer drives metastatic p

NIAID Data Ecosystem20

MOESM1 of A novel epigenetic signature for overall survival prediction in patients with breast cancer

资源简介：

相关数据集